Trying to ConceiveNCT07862829
Integration of the Oura Ring and Maven Clinic Among Women Who Are Trying to Conceive
An observational study of Trying to Conceive, run by Ouraring Inc. at 1 site in United States.
Trial summary
This study aims to characterize Oura Ring users who are trying to conceive. It also evaluates the feasibility and clinical outcomes of integrating Oura data with Maven's clinical support platform. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Trying to Conceive
- How many people
- 50,000 participants
- Where
- 1 siteUnited States
- Study dates
- 29 Jul 2026to 29 Jul 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Individuals residing in the United States who use Oura Ring and self identify as trying to conceive.
Who may be able to join
- 18-45 years old Female sex at birth Currently trying to conceive Able to provide consent electronically Have an Oura Ring (Gen 3 or newer) with an active account Can communicate and provide consent using written and spoken English Lives in the US
Who cannot join
- Currently using hormonal contraceptives Currently pregnant
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Maven Clinic
New York, New York, 10013
Hannah Jahnke, PhD, 877-628-3483, research@mavenclinic.com
About this study
Official title: Integration of the Oura Ring and Maven Clinic Among Women Who Are Trying to Conceive: A Longitudinal Exploration of User Characteristics, Health-related Behaviors and Clinical Outcomes
This study aims to characterize Oura Ring users who are trying to conceive. It also evaluates the feasibility and clinical outcomes of integrating Oura data with Maven's clinical support platform.
- Conditions
- Trying to Conceive
- Keywords
- Fertility, Pregnancy, Conception
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary Outcome Measure
To describe users who are trying to conceive with the use of Maven and/or the Oura Ring, including their health characteristics, knowledge on trying to conceive, stage along their conception journey, reproductive history and behaviors, and engagement with health resources.
Measured: Up to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2026
- Study start29 Jul 2026
- Primary completion29 Jul 2029 (estimated)
- Study completion29 Jul 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Trying to ConceiveStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ouraring Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Maven Clinic
- Responsible party
- Sponsor
- Investigators
- Natalie Henrich, PhD, MPH, Principal investigator, Maven Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07862829
- Sponsor's protocol ID
- 1407014
- Status last verified
- Oct 2026
- First submitted
- 2 Oct 2026
- Last updated
- 7 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Integration of the Oura Ring and Maven Clinic Among Women Who Are Trying to Conceive: A Longitudinal Exploration of User Characteristics, Health-related Behaviors and Clinical Outcomes
- ClinicalTrials.gov ID
- NCT07862829
- Acronym / sponsor ID
- 1407014
- Conditions
- Trying to Conceive
- Keywords
- Fertility, Pregnancy, Conception
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50,000 participants (estimated)
- Lead sponsor
- Ouraring Inc.Industry (pharma, biotech, devices)
- Collaborators
- Maven Clinic
- Study start
- 29 Jul 2026 (actual)
- Primary completion
- 29 Jul 2029 (estimated)
- Study completion
- 29 Jul 2029 (estimated)
- First posted
- 7 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to characterize Oura Ring users who are trying to conceive. It also evaluates the feasibility and clinical outcomes of integrating Oura data with Maven's clinical support platform.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Individuals residing in the United States who use Oura Ring and self identify as trying to conceive.
Key inclusion criteria (1 listed)
- 18-45 years old Female sex at birth Currently trying to conceive Able to provide consent electronically Have an Oura Ring (Gen 3 or newer) with an active account Can communicate and provide consent using written and spoken English Lives in the US
Key exclusion criteria (1 listed)
- Currently using hormonal contraceptives Currently pregnant
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Primary Outcome Measure
Time frame: Up to 12 months
To describe users who are trying to conceive with the use of Maven and/or the Oura Ring, including their health characteristics, knowledge on trying to conceive, stage along their conception journey, reproductive history and behaviors, and engagement with health resources.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Trying to Conceive
RecruitingObservational study
Biobank Cycle Collection
Pregnancy
Recruiting
Physical Activity, Fertility, and Spontaneous Abortion in Danish Couples Trying to Conceive
Fertility, Fecundability
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Natalie Henrich, PhD, MPH principal investigator
Maven Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Trying to Conceive, run by Ouraring Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hannah Jahnke, PhD (877-628-3483, research@mavenclinic.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary Outcome Measure (time frame: Up to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.